Literature DB >> 10726294

[Measurement of quality of life in patients with dementia of Alzheimer type and their caregivers: Schedule for the Evaluation of Individual Quality of Life (SEIQoL)].

C J Schölzel-Dorenbos1.   

Abstract

Twelve patients with mild to moderate Alzheimer's Disease (AD) and their caregivers were interviewed with the SEIQoL. The SEIQoL measures quality of life by taking into account the relevant determinants for a particular individual. The subject rates 5 areas in life most important to the quality of life. The relative contribution of each area to the overall quality of life is then calculated with a multiple regression analysis programme developed for the purpose. Next the SEIQoL Index score, validity and reliability are computed. One patient was unable to complete the interview. The remaining (8 women, 3 men, mean age 71.3 years) had a mean SEIQoL Index score of 79.9 (median: 85.4), which is comparable to healthy Dutch elderly. The caregivers (10 spouses, 2 daughters; mean age 67.4 years), on the other hand, had a lower SEIQoL Index score: 62.2 (median: 63.8). Validity and reliability were good for both groups. Thus, caregivers in this pilot study experienced a lower quality of life than AD patients and healthy Dutch elderly. The SEIQoL allows quantitative measurement of completely individualised quality of life for AD patients and their caregivers.

Entities:  

Mesh:

Year:  2000        PMID: 10726294

Source DB:  PubMed          Journal:  Tijdschr Gerontol Geriatr        ISSN: 0167-9228


  2 in total

Review 1.  A review of quality of life instruments used in dementia.

Authors:  Teake P Ettema; Rose-Marie Dröes; Jacomine de Lange; Gideon J Mellenbergh; Miel W Ribbe
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

2.  Problems eliciting cues in SEIQoL-DW: quality of life areas in small-cell lung cancer patients.

Authors:  Marjan Westerman; Tony Hak; Anne-Mei The; Harry Groen; Gerrit van der Wal
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.